| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.34 | 0.02 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |